Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001015504 | SCV001176344 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-12-28 | criteria provided, single submitter | clinical testing | The c.242dupA pathogenic mutation, located in coding exon 3 of the ATM gene, results from a duplication of A at nucleotide position 242, causing a translational frameshift with a predicted alternate stop codon (p.N81Kfs*19). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Cancer Genomics Group, |
RCV001030451 | SCV001193463 | likely pathogenic | Hereditary breast ovarian cancer syndrome | 2019-05-01 | criteria provided, single submitter | research |